Intel and Asus: Letting AI Fly Can Save Lives

Intel and Asus. Letting AI Fly Can Save Lives

The News: Intel and ASUS announced in a recent blog post that ASUS is using Intel’s 11th Generation Intel Core Processor to power its ASUS EndoAIM Endoscopy System, which assists gastroenterologists and gastrointestinal surgeons in identifying and classifying real-time colonoscopy images leveraging AI. Read the Intel blog post for more information.

Intel and Asus: Letting AI Fly Can Save Lives

Intel and Asus
Image Source: Intel

Analyst Take: A key market for AI-based solutions is the business-to-business (B2B) sector, where working professionals are leveraging AI to augment their job functions as an extra guide, which is key for critical areas such as medical diagnostics that can mean life or death. To help healthcare organizations speed up and improve their diagnostic care, ASUS is leveraging the Intel 11th Generation Intel Core Processor to power its ASUS EndoAIM Endoscopy Systems, which help diagnostic professionals discern between polyps that are areas of concern versus those that are not.

The Market for AI-based Medical Diagnostics

The market for AI-based medical diagnostics is on the rise and is projected to grow north of a 20% compound annual growth rate (CAGR) over the next several years. The following are key catalysts for AI-based medical diagnostics.

  • Aging Populations: Growth of aging populations that represent significant portions of populations in North America, Asia Pacific, and EMEA.
  • Reducing Miss Rates: Augment the radiologist in identifying potential areas of concern that can sometimes be missed. In fact, AI-assisted colonoscopies reduce the miss rate by 50%. Thus, AI-infused medical devices can also be part of the organization’s risk mitigation strategy.
  • Margin Accretion Strategy: Radiology is one of the highest-margin departments of the hospital. Therefore, it also behooves management teams at the hospital to adopt AI-infused solutions that will help accelerate traffic.

Intel and Asus Collaboration

To help ASUS come up with an optimal solution for its clients, both Intel and ASUS collaborated and decided to come up with a smaller form factor to conserve space coupled with using the Intel 11th Generation CPU featuring Intel Iris X graphics.

The ASUS EndoAIM Endoscopy System helps diagnostic professionals discern between polyps that are areas of concern by classifying abnormalities by taking out the guesswork. To help ASUS fine-tune the ASUS EndoAIM Endoscopy device to find those abnormalities, Intel engineers leveraged its OpenVINO open-source software toolkit to quickly develop code to accelerate the development of the ASUS EndoAIM Endoscopy device.

This is an excellent win and use case for Intel, ASUS, and AI since the ASUS EndoAIM Endoscopy device will augment diagnostic teams and undoubtedly save lives in the future since AI-assisted colonoscopies reduce the miss rate by 50%.
Disclosure: The Futurum Group is a research and advisory firm that engages or has engaged in research, analysis, and advisory services with many technology companies, including those mentioned in this article. The author does not hold any equity positions with any company mentioned in this article.

Analysis and opinions expressed herein are specific to the analyst individually and data and other information that might have been provided for validation, not those of The Futurum Group as a whole.

Other insights from Futurum Research:

5G Factor: Chips Ahoy! How Chips are Integral to 5G Transformation with Qualcomm Promoting 5G Standalone, Juniper Beyond Labs Using Intel Xeon/FlexRAN, and Samsung MediaTek Boosting 3Tx Antennas 

Intel x86 Architecture: Architectural Consistency – The Best Assurance in Avoiding Costly New Support Structures 

Intel Meteor Lake: Placing Bets on On-Device AI 

Image Credit: Intel
Related Insights
Conduent's $447M Refinancing Clears the Path for AI-Led Growth
October 24, 2026

Conduent's $447M Refinancing Clears the Path for AI-Led Growth

Conduent closed a $447 million refinancing deal, extending credit facilities and reducing financial risk while enabling execution of its ASCEND 2026–28 strategic plan to become a premier AI-led business process...
IBM Q3 FY 2026 Software Growth and Deal Recovery Lift Execution
October 23, 2026

IBM Q3 FY 2026: Software Growth and Deal Recovery Lift Execution

Futurum Research examines IBM’s Q3 FY 2026 earnings, including software execution, infrastructure deal recovery, sovereign AI demand, and consulting delivery efficiency....
SAP Q3 FY 2026 AI and Data Integration Expand Cloud Adoption
October 23, 2026

SAP Q3 FY 2026: AI and Data Integration Expand Cloud Adoption

Futurum Research analyzes SAP’s Q3 FY 2026 earnings, examining AI-led cloud migration, enterprise data integration, and the shift toward adoption-based economics....
WEKA and Smartbird End the Sovereignty-Performance Tradeoff
October 23, 2026

WEKA and Smartbird End the Sovereignty-Performance Tradeoff

WEKA and Smartbird announced a strategic partnership to deliver sovereign managed AI infrastructure for regulated enterprises in government, healthcare, and financial services, combining NeuralMesh software with dedicated clusters....
Sword Group's 17% Organic Growth Validates AI Transformation Bet
October 23, 2026

Sword Group's 17% Organic Growth Validates AI Transformation Bet

Sword Group achieved 17.1% organic growth in Q3 2026 with €100.2M revenue, driven by major EU and enterprise contract wins that validate its AI transformation strategy and position it for...
Western Digital's 55% Revenue Surge Signals AI Storage Boom
October 23, 2026

Western Digital's 55% Revenue Surge Signals AI Storage Boom

Western Digital's Q1 FY2027 revenue surged 55% to $4.38 billion with non-GAAP EPS jumping 161% to $4.64, driven by hyperscaler and cloud AI-storage investments positioning the company to capitalize on...

Book a Demo

Welcome

The vision behind everything in Futurum’s Custom Research practice is this: research should show you what is happening, what comes next, and what to do about it. It should be personal to each audience, easy for people to grasp, and structured so LLMs can reason over it accurately. And it should be fast and turnkey; you want answers now, not another project to carry for quarters.

Whether you are defining business, channel, or go-to-market strategy; evaluating vendors or justifying ROI; or commissioning research to fill an emerging market need, we have your back, with a program that answers your questions with the objectivity and credibility to drive real decisions.

To do it, we bring unmatched data to bear: Futurum research, surveys, and market projections; validated market feeds; ETR’s 15 years of insight from 10,000 technology decision-makers; G2’s buyer and user data; and what our analysts hear every day. Add leading primary collection, from AI-moderated voice interviews to surveys and analyst-led interviews, all turnkey, and every project comes out credible, nuanced, and actionable.

And we don’t just drop the results in your lap. For internal work, we provide analyst-led sessions, interactive dashboards, and a range of formats. For market-facing work, Futurum delivers turnkey activation and amplification that actually gets seen, by people and by LLMs, through our media and share of voice. This is research that moves decisions and markets.

We will meet you wherever you are, from a fast-turn brief to a multi-year program, and shape the work to your goals, timeline, and budget. The right program for your moment.

If any of this is useful, I would love to talk.

Benjamin Brown, VP Custom Research, Futurum Research

Benjamin Brown

VP, Custom Research · The Futurum Group

Newsletter Sign-up Form

Get important insights straight to your inbox, receive first looks at eBooks, exclusive event invitations, custom content, and more. We promise not to spam you or sell your name to anyone. You can always unsubscribe at any time.

All fields are required






Thank you, we received your request, a member of our team will be in contact with you.